We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03381183
Brief Title: IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma

First Submitted : December 18, 2017
First Submitted that Met QC Criteria : December 18, 2017
First Posted : December 21, 2017

Last Update Submitted that Met QC Criteria : September 30, 2022
Last Update Posted : October 3, 2022